Efficacy of infliximab therapy for refractory pouchitis
Phase 1
- Conditions
- ulcerative colitis, pouchitis
- Registration Number
- JPRN-UMIN000013370
- Lead Sponsor
- Inflammatory bowel disease center, Hyogo college of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with pre-existed malignancy, other infectious disease, heart failure, or infusion reaction for infliximab
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of infliximab treatment will be assessed with pouchitis disease activity index before and after treatment
- Secondary Outcome Measures
Name Time Method Evaluate the association between dose of anti-TNF alpha before treatment and efficacy of treatment